Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Peter Maguire"'
Autor:
Lin Fan, Yuanyuan Zhang, Peter Maguire, Dominic Muston, Matthew Monberg, Jagadeswara Rao Earla, Adela Mihai, Poonam Gulati
Publikováno v:
Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)
Background The economic impact of adverse events (AEs) for poly (ADP-ribose) polymerase inhibitors (PARPis) in ovarian or breast cancer has not been widely evaluated.Objective Compare PARPi-related AE management costs from a US payer perspective.Meth
Externí odkaz:
https://doaj.org/article/532a45d6ad764ab28ad68d2453728796
Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
Publikováno v:
J Thorac Dis
Background Small-cell lung cancer (SCLC) accounts for 12-15% of lung cancers and is associated with poor survival outcomes and high symptom burden. This study employed a broad, systematic search strategy and timeframe to identify evidence on real-wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab134ef6a1cd3c3962b4b96fd6b1fe1
https://europepmc.org/articles/PMC8264706/
https://europepmc.org/articles/PMC8264706/
Autor:
Jameel Nazir, Emma Geldman, Peter Maguire, Adrian C. Newland, Tammy Wynne, Vickie McDonald, Mervyn Morgan, Koo Wilson
OBJECTIVES To establish the experiences with and preferences towards existing thrombopoietin-receptor agonist (TPO-RA) treatments of individuals with immune thrombocytopenia (ITP) in the UK and Ireland, based on treatment attributes. METHODS Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8f47a61905bce43476aee5a94d10b11
Autor:
Peter Maguire
Publikováno v:
Australian Prescriber. 45:41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aab95e065b4e0280a9b77bbdddd1b9ac
https://doi.org/10.18773/austprescr.2022.019
https://doi.org/10.18773/austprescr.2022.019
Autor:
Peter Maguire
Publikováno v:
Journal of American History. 107:433-434
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8667f80e007b21e2256e272f20494f4
https://doi.org/10.1093/jahist/jaaa251
https://doi.org/10.1093/jahist/jaaa251
Autor:
Patrick Zhang, Gongyong Peng, Aiqin Cao, Yesl Kim, Shravani Pasupneti, Michael Snyder, Hassan Chaib, Ting Hsuan Wu, Yon K. Sung, Marlene Rabinovitch, Wen Tian, Norbert F. Voelkel, Allen B. Tu, Xinguo Jiang, Peter Maguire, Petra Dahms, Lingli Wang, Mark R. Nicolls, Marc Peters-Golden, Peter N. Kao, Marc Humbert, Peter Dorfmüller, Eric M. Shuffle, Roham T. Zamanian, James Chappell
Publikováno v:
Tian, W, Jiang, X, Sung, Y K, Shuffle, E, Wu, T H, Kao, P N, Tu, A B, Dorfmüller, P, Cao, A, Wang, L, Peng, G, Kim, Y, Zhang, P, Chappell, J, Pasupneti, S, Dahms, P, Maguire, P, Chaib, H, Zamanian, R, Peters-Golden, M, Snyder, M P, Voelkel, N F, Humbert, M, Rabinovitch, M & Nicolls, M R 2019, ' Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation ', Circulation, vol. 140, no. 17, pp. 1409-1425 . https://doi.org/10.1161/CIRCULATIONAHA.119.040629
Circulation, 140(17), 1409-1425. Lippincott Williams and Wilkins
Circulation
Circulation, 140(17), 1409-1425. Lippincott Williams and Wilkins
Circulation
Background: Bmpr2 (bone morphogenetic protein receptor 2) mutations are critical risk factors for hereditary pulmonary arterial hypertension (PAH) with approximately 20% of carriers developing disease. There is an unmet medical need to understand how
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a558c2d58d84632a97d1facafc6e68f1
https://research.vumc.nl/en/publications/83bc2207-15ad-48bd-9cf4-41ce521da2eb
https://research.vumc.nl/en/publications/83bc2207-15ad-48bd-9cf4-41ce521da2eb
Autor:
Ian Crosby, Vincent Yip, Munir Pirmohamed, Peter Maguire, Christopher Taylor, Richard M. Turner
Publikováno v:
Genes
Genes, Vol 11, Iss 1295, p 1295 (2020)
Genes, Vol 11, Iss 1295, p 1295 (2020)
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of ~20% of commonly used drugs across a broad spectrum of medical disciplines including psychiatry, pain management, oncology and cardiology. Nevertheless, CYP2D6 is h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ca6854ef1af401766bcc6090c1d4bc
https://doi.org/10.3390/genes11111295
https://doi.org/10.3390/genes11111295
Autor:
Peter Maguire, Jayakumar Rajadas, Kwang-Min Kim, Hari Hara Potula, Lobat Tayebi, Mansi B Parekh, Venkata Raveendra Pothineni, Mohammed Inayathullah, Aditya Ambati, Mustafeez Mujtaba Babar
Publikováno v:
Drug design, development and therapy. 12
Venkata Raveendra Pothineni,1,* Mansi B Parekh,1,* Mustafeez Mujtaba Babar,1 Aditya Ambati,2 Peter Maguire,1 Mohammed Inayathullah,1 Kwang-Min Kim,1 Lobat Tayebi,3 Hari-Hara SK Potula,1 Jayakumar Rajadas1,4 1Biomaterials and Advanced Drug Delivery, S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::953c0f5a4fb99f5df8a9e52150defd6c
https://pubmed.ncbi.nlm.nih.gov/30254421
https://pubmed.ncbi.nlm.nih.gov/30254421
Autor:
Chaturvedi, Santosh K.1 (AUTHOR) chatur@nimhans.kar.nic.in, Peter Maguire, G.2 (AUTHOR), Somashekar, B. S.3 (AUTHOR)
Publikováno v:
International Review of Psychiatry. Feb2006, Vol. 18 Issue 1, p49-54. 6p.
Publikováno v:
Physics of the Earth and Planetary Interiors. :1-15
The upper mantle beneath the Alps and the Variscides of Central Europe has a varied seismic structure as a result of the accretionary and evolutionary processes that have shaped it. Natural earthquake data, the raypaths of which pass beneath these re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29ae2cd175af82dc25ebc1df6659b4e2
https://doi.org/10.1016/j.pepi.2012.06.001
https://doi.org/10.1016/j.pepi.2012.06.001